Holash J, Maisonpierre P C, Compton D, Boland P, Alexander C R, Zagzag D, Yancopoulos G D, Wiegand S J
Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Science. 1999 Jun 18;284(5422):1994-8. doi: 10.1126/science.284.5422.1994.
In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead initially grows by coopting existing host vessels. This coopted host vasculature does not immediately undergo angiogenesis to support the tumor but instead regresses, leading to a secondarily avascular tumor and massive tumor cell loss. Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. The expression patterns of the angiogenic antagonist angiopoietin-2 and of pro-angiogenic vascular endothelial growth factor (VEGF) suggest that these proteins may be critical regulators of this balance between vascular regression and growth.
与大多数肿瘤和转移灶起始于无血管肿块的主流观点相反,本文提供的证据表明,一部分肿瘤最初是通过利用现有的宿主血管生长的。这种被利用的宿主脉管系统不会立即发生血管生成以支持肿瘤,而是会退化,导致继发性无血管肿瘤和大量肿瘤细胞丢失。然而,最终,剩余的肿瘤通过肿瘤边缘强大的血管生成得以挽救。血管生成拮抗剂血管生成素-2和促血管生成的血管内皮生长因子(VEGF)的表达模式表明,这些蛋白质可能是血管退化与生长之间这种平衡的关键调节因子。